## **Core Concept**
Glanzmann thrombasthenia is a bleeding disorder characterized by the dysfunction of platelets, specifically related to their inability to aggregate properly. This condition is associated with abnormalities in platelet surface glycoproteins. It is an inherited disorder that affects the platelet glycoprotein IIb/IIIa complex.

## **Why the Correct Answer is Right**
The correct answer, , refers to a qualitative or quantitative deficiency of the glycoprotein IIb/IIIa (GP IIb/IIIa) complex on the platelet surface. This complex, also known as integrin αIIbβ3, plays a crucial role in platelet aggregation by acting as a receptor for fibrinogen and von Willebrand factor. In Glanzmann thrombasthenia, platelets cannot aggregate because they lack or have dysfunctional GP IIb/IIIa receptors, leading to impaired clot formation and increased bleeding tendency.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because Glanzmann thrombasthenia is not primarily related to a deficiency of factor VIII; that's more closely associated with Hemophilia A.
- **Option B:** This option is incorrect as it refers to a condition related to von Willebrand factor or factor VIII, not directly related to the pathophysiology of Glanzmann thrombasthenia.
- **Option D:** This option is incorrect because Bernard-Soulier syndrome, while also a platelet disorder, is characterized by a deficiency or dysfunction of the GPIb-IX-V complex, not the GPIIb/IIIa complex.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that patients with Glanzmann thrombasthenia typically have a normal platelet count and size but exhibit impaired platelet aggregation. Clinically, this results in mucocutaneous bleeding, easy bruising, and a high risk of bleeding with surgeries or trauma. Laboratory diagnosis often involves platelet aggregometry showing failure of platelets to aggregate in response to agonists.

## **Correct Answer:** . Glanzmann thrombasthenia